| 【Company Research】Kintor Pharmaceutical (9939 HK) – Proxalutamide’s 2L+ mCRPC Phase III trial needs to wait for OS data |
| 【Company Research】China Pacific Insurance (2601 HK) – Investor day on P&C achievements |
| 【行业研究】中国新能源汽车 – 特斯拉电池日回顾 – 特斯拉到底在下什么棋？ |
| 【公司研究】终止覆盖 |
| 【Company Research】Aoyuan Healthy Life (3662 HK) – M&A explores new healthcare dimension |
| 【行业研究】中国新能源汽车 – 特斯拉电池日前瞻：以故事拼图的思维看特斯拉电池日 |
| 【公司研究】睿见教育 (6068 HK) – 价值吸引，重申买入 |
| 【Sector Research】China Solar Sector – 14th FYP preview: lifting non-fossil energy mix will boost 2021-25E PV installation |
| 【Company Research】InnoCare Pharma (9969 HK) – Well prepared for the first product commercialization |
| 【Sector Research】China Technology Sector – New Apple Watch, iPad and Services Bundle Unveiled; Positive to BYDE and Luxshare |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
